-
-
-
-
-
-
-
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
-
-
-
-
-
-
-
Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Humana Inc. (NYSE: HUM); Five Below, Inc. (NASDAQ: FIVE); and Hertz Global Holdings, Inc. (NASDAQ: HTZ): Grab
-
-
-
-
-
-
-
Amylyx Pharmaceuticals to Host Event to Discuss Post-bariatric Hypoglycemia and Avexitide at ENDO 2025
-
-
-
-
-
-
-
Amylyx Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
-
-
-
-
-
-
-
Amylyx Pharmaceuticals (AMLX) Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Trial
-
-
-
-
-
-
-
Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
-
-
-
-
-
-
-
Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
-
1,200,157 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

